Sign in
CompletedNo phase

DISSECT-N Post Market Data Collection Registry

Key facts

Who runs it
Medtronic Cardiovascular
Where
Albany, Ann Arbor, Atlanta, Birmingham, Charleston, Charlotte, Gainesville, Harrisburg, New York, Norfolk, Philadelphia, and Plano, United StatesSee the 12 sitesAlso in 9 other countries, 10 sites
Trial code
Status
Completed
People taking part
102 people enrolled
Started
25 Jun 2020
Ended
5 Jul 2024
Type of study
Observational
Treatments tested
  • Valiant Navion Thoracic Stent Graft System
Record updated
3 July 2025

Who can take part

Age
18 years and older
Sex
Women and men

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Subject is ≥18 years old
  • Subject was treated in the last 7 days, or is intended to be treated, with the Valiant Navion Thoracic Stent Graft System for a dissection in the thoracic aorta
  • Subject is willing to comply with standard of care clinical follow-up
  • Subject or legal representative or consultee, as applicable has consented for study participation and signed the approved Informed Consent

Who cannot take part

  • Subject is participating in an investigational drug or device study which may bias or interfere with the endpoints and follow-up of this study
  • Subject has an active COVID-19 infection or relevant history of COVID-19. Relevant history of COVID-19 is defined as availability of a positive COVID-19 test with sequela or hospitalization for treatment of COVID-19. Subjects with a positive COVID-19 test who were asymptomatic or had mild symptoms should be excluded only if the positive test was less than 3 months prior to enrollment
  • Subject is pregnant (not an exclusion if allowed per local regulatory requirements, pregnancy test to be performed where required)

Where in United States

Also in 9 other countries, 10 sites

  • Albany Medical CenterAlbany, United States
  • University of Michigan Health System - University HospitalAnn Arbor, United States
  • Emory University HospitalAtlanta, United States
  • University of Alabama At Birmingham HospitalBirmingham, United States
  • Medical University of South CarolinaCharleston, United States
  • Atrium Health's Carolinas Medical CenterCharlotte, United States
  • University of Florida Health Shands HospitalGainesville, United States
  • UPMC Pinnacle Harrisburg CampusHarrisburg, United States
  • Northwell Health- Lenox Hill HospitalNew York, United States
  • Sentara Norfolk General HospitalNorfolk, United States
  • Hospital of the University of PennsylvaniaPhiladelphia, United States
  • Baylor - PlanoPlano, United States

About the trial

What the trial wants to find out

DISSECT-N is a post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.

Treatments tested

  • Valiant Navion Thoracic Stent Graft System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
DISSECT-N (Dissection Navion Registry)
Record updated
3 July 2025